Candel Therapeutics (CADL) Profit After Tax (2020 - 2025)
Candel Therapeutics recorded quarterly Profit After Tax of -$29.5 million in Q4 2025, down 161.62% quarter-over-quarter from -$11.3 million in Q3 2025, and down 109.15% year-over-year from $322.2 million in Q4 2024.
Candel Therapeutics' Profit After Tax history runs 6 years deep, the most recent figure standing at -$29.5 million for Q4 2025.
- In Q4 2025, Profit After Tax fell 109.15% year-over-year to -$29.5 million; the TTM figure through Dec 2025 stood at -$38.2 million (up 30.83% YoY), while the FY2025 annual figure was -$38.2 million, up 30.83% from the prior year.
- Profit After Tax came in at -$29.5 million for Q4 2025 at Candel Therapeutics, down from -$11.3 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $7.4 million in Q1 2025 to a low of -$29.5 million in Q4 2025.
- A 5-year average of -$9.3 million and a median of -$8.7 million in 2022 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax sank 877.22% in 2023 and surged 189.99% in 2025, its largest moves.
- Candel Therapeutics' Profit After Tax stood at $1.6 million in 2021, then plunged by 418.48% to -$5.1 million in 2022, then sank by 118.37% to -$11.1 million in 2023, then retreated by 26.99% to -$14.1 million in 2024, then slumped by 109.15% to -$29.5 million in 2025.
- According to Business Quant data, Profit After Tax over the past three periods registered -$29.5 million, -$11.3 million, and -$4.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Candel Therapeutics | 449.62 Mn | 449.62 Mn | - | -29.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -29.48 Mn |
| Sep 30, 2025 | -11.27 Mn |
| Jun 30, 2025 | -4.80 Mn |
| Mar 31, 2025 | 7.38 Mn |
| Dec 31, 2024 | -14.10 Mn |
| Sep 30, 2024 | -10.65 Mn |
| Jun 30, 2024 | -22.24 Mn |
| Mar 31, 2024 | -8.20 Mn |
| Dec 31, 2023 | -11.10 Mn |
| Sep 30, 2023 | -8.44 Mn |
| Jun 30, 2023 | -9.61 Mn |
| Mar 31, 2023 | -8.80 Mn |
| Dec 31, 2022 | -5.08 Mn |
| Sep 30, 2022 | -8.69 Mn |
| Jun 30, 2022 | -4.15 Mn |
| Mar 31, 2022 | -900,000.00 |
| Dec 31, 2021 | 1.60 Mn |
| Sep 30, 2021 | -16.16 Mn |
| Jun 30, 2021 | -17.08 Mn |
| Mar 31, 2021 | -4.48 Mn |
| Dec 31, 2020 | -10.48 Mn |
| Sep 30, 2020 | -2.55 Mn |
| Jun 30, 2020 | -2.88 Mn |